secwatch.observer — SEC 8-K summary
======================================

Issuer:     BeOne Medicines Ltd. (ONC)
CIK:        0001651308
Form:       8-K
Filed at:   2024-03-08T23:59:59+00:00
Accession:  0001651308-24-000021
Event type: litigation
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeiGene files patent suits against Sandoz and MSN to block generic BRUKINSA until 2034
--------------------------------------------------------------------------------

- Filed Hatch-Waxman infringement suits in District of New Jersey after Sandoz and MSN filed ANDAs with Paragraph IV certifications.
- Composition of matter patent for BRUKINSA not challenged; remains intact and expires in 2034.
- Complaints seek permanent injunction to prevent generic commercialization before expiration of asserted Orange Book patents.
- ANDA litigation common in pharma; additional notices from other generic companies may follow.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1651308/000165130824000021/0001651308-24-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1651308/000165130824000021/bgne-20240308.htm
  HTML page:      https://secwatch.observer/filing/0001651308-24-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer